Evidence map›Paper›PMID 25790188›Full record

ArticlePloS one2015

A method for multiplex gene synthesis employing error correction based on expression.

Timothy H-C Hsiau, David Sukovich, Phillip Elms, Robin N Prince, Tobias Strittmatter, Tobias Stritmatter, Paul Ruan, Bo Curry, Paige Anderson, Jeff Sampson and 1 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Timothy H-C HsiauDepartment of Bioengineering, University of California, Berkeley, CA, United States of America.
David SukovichDepartment of Bioengineering, University of California, Berkeley, CA, United States of America.
Phillip ElmsDepartment of Bioengineering, University of California, Berkeley, CA, United States of America.
Robin N PrinceDepartment of Bioengineering, University of California, Berkeley, CA, United States of America.
Tobias Strittmatter
Tobias StritmatterDepartment of Bioengineering, University of California, Berkeley, CA, United States of America.
Paul RuanDepartment of Electrical Engineering and Computer Science, University of California, Berkeley, CA, United States of America.
Bo CurryAgilent Technologies, Santa Clara, CA, United States of America.
Paige AndersonAgilent Technologies, Santa Clara, CA, United States of America.
Jeff SampsonAgilent Technologies, Santa Clara, CA, United States of America.
J Christopher AndersonDepartment of Bioengineering, University of California, Berkeley, CA, United States of America; Synthetic Biology Institute, University of California, Berkeley, CA, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our ability to engineer organisms with new biosynthetic pathways and genetic circuits is limited by the availability of protein characterization data and the cost of synthetic DNA. With new tools for reading and writing DNA, there are opportunities for scalable assays that more efficiently and cost effectively mine for biochemical protein characteristics. To that end, we have developed the Multiplex Library Synthesis and Expression Correction (MuLSEC) method for rapid assembly, error correction, and expression characterization of many genes as a pooled library. This methodology enables gene synthesis from microarray-synthesized oligonucleotide pools with a one-pot technique, eliminating the need for robotic liquid handling. Post assembly, the gene library is subjected to an ampicillin based quality control selection, which serves as both an error correction step and a selection for proteins that are properly expressed and folded in E. coli. Next generation sequencing of post selection DNA enables quantitative analysis of gene expression characteristics. We demonstrate the feasibility of this approach by building and testing over 90 genes for empirical evidence of soluble expression. This technique reduces the problem of part characterization to multiplex oligonucleotide synthesis and deep sequencing, two technologies under extensive development with projected cost reduction.

Indexed as

Genes, SyntheticDNAEscherichia coliGene Expression RegulationHigh-Throughput Nucleotide SequencingOligonucleotide Array Sequence AnalysisOligonucleotidesProtein BiosynthesisDNAOligonucleotides

Identifiers

PMID25790188
PMCPMC4366238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.